166 related articles for article (PubMed ID: 37850423)
1. Differential cellular responses to FDA-approved nanomedicines: an exploration of albumin-based nanocarriers and liposomes in protein corona formation.
Putri AD; Hsu MJ; Han CL; Chao FC; Hsu CH; Lorenz CD; Hsieh CM
Nanoscale; 2023 Nov; 15(44):17825-17838. PubMed ID: 37850423
[TBL] [Abstract][Full Text] [Related]
2. In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.
Kari OK; Ndika J; Parkkila P; Louna A; Lajunen T; Puustinen A; Viitala T; Alenius H; Urtti A
Nanoscale; 2020 Jan; 12(3):1728-1741. PubMed ID: 31894806
[TBL] [Abstract][Full Text] [Related]
3. Modulation of serum albumin protein corona for exploring cellular behaviors of fattigation-platform nanoparticles.
Nguyen VH; Meghani NM; Amin HH; Tran TTD; Tran PHL; Park C; Lee BJ
Colloids Surf B Biointerfaces; 2018 Oct; 170():179-186. PubMed ID: 29906703
[TBL] [Abstract][Full Text] [Related]
4. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
5. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
6. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
Yang K; Mesquita B; Horvatovich P; Salvati A
Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
[TBL] [Abstract][Full Text] [Related]
7. Unravelling the role of lipid composition on liposome-protein interactions.
Nele V; D'Aria F; Campani V; Silvestri T; Biondi M; Giancola C; De Rosa G
J Liposome Res; 2024 Mar; 34(1):88-96. PubMed ID: 37337884
[TBL] [Abstract][Full Text] [Related]
8. The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
Hadjidemetriou M; McAdam S; Garner G; Thackeray C; Knight D; Smith D; Al-Ahmady Z; Mazza M; Rogan J; Clamp A; Kostarelos K
Adv Mater; 2019 Jan; 31(4):e1803335. PubMed ID: 30488990
[TBL] [Abstract][Full Text] [Related]
9. Effects of Protein Source on Liposome Uptake by Cells: Corona Composition and Impact of the Excess Free Proteins.
Yang K; Reker-Smit C; Stuart MCA; Salvati A
Adv Healthc Mater; 2021 Jul; 10(14):e2100370. PubMed ID: 34050634
[TBL] [Abstract][Full Text] [Related]
10. Pre-coating cRGD-modified bovine serum albumin enhanced the anti-tumor angiogenesis of siVEGF-loaded chitosan-based nanoparticles by manipulating the protein corona composition.
Wu Z; Yuan C; Xia Q; Qu Y; Yang H; Du Q; Xu B
Int J Biol Macromol; 2024 May; 267(Pt 2):131546. PubMed ID: 38614172
[TBL] [Abstract][Full Text] [Related]
11. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes.
Fleischer CC; Payne CK
Acc Chem Res; 2014 Aug; 47(8):2651-9. PubMed ID: 25014679
[TBL] [Abstract][Full Text] [Related]
13. Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients.
Colapicchioni V; Tilio M; Digiacomo L; Gambini V; Palchetti S; Marchini C; Pozzi D; Occhipinti S; Amici A; Caracciolo G
Int J Biochem Cell Biol; 2016 Jun; 75():180-7. PubMed ID: 26369869
[TBL] [Abstract][Full Text] [Related]
14. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
15. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
17. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic dendrimers control protein binding and corona formation on liposome nanocarriers.
Wagner J; Dillenburger M; Simon J; Oberländer J; Landfester K; Mailänder V; Ng DYW; Müllen K; Weil T
Chem Commun (Camb); 2020 Aug; 56(61):8663-8666. PubMed ID: 32608398
[TBL] [Abstract][Full Text] [Related]
19. Protein corona precoating on redox-responsive chitosan-based nano-carriers for improving the therapeutic effect of nucleic acid drugs.
Yang H; Liu T; Xu Y; Su G; Liu T; Yu Y; Xu B
Carbohydr Polym; 2021 Aug; 265():118071. PubMed ID: 33966835
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in silico protein corona formation evaluation of curcumin and capsaicin loaded-solid lipid nanoparticles.
Nishihira VSK; Rubim AM; Brondani M; Dos Santos JT; Pohl AR; Friedrich JF; de Lara JD; Nunes CM; Feksa LR; Simão E; de Almeida Vaucher R; Durruthy MG; Laporta LV; Rech VC
Toxicol In Vitro; 2019 Dec; 61():104598. PubMed ID: 31299314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
